
Nita M. Minnifield
Examiner (ID: 17178, Phone: (571)272-0860 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1817, 1621, 1645, 1802, 1813 |
| Total Applications | 1564 |
| Issued Applications | 1017 |
| Pending Applications | 126 |
| Abandoned Applications | 425 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14662595
[patent_doc_number] => 10369174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient
[patent_app_type] => utility
[patent_app_number] => 15/534068
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 50
[patent_no_of_words] => 9860
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/534068 | Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient | Dec 7, 2015 | Issued |
Array
(
[id] => 10806573
[patent_doc_number] => 20160152732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'ANTIBODIES DIRECTED TO RICIN TOXIN'
[patent_app_type] => utility
[patent_app_number] => 14/952283
[patent_app_country] => US
[patent_app_date] => 2015-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15251
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14952283
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/952283 | Antibodies directed to ricin toxin | Nov 24, 2015 | Issued |
Array
(
[id] => 13179867
[patent_doc_number] => 10105421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Therapeutic composition with a botulinum neurotoxin
[patent_app_type] => utility
[patent_app_number] => 14/950587
[patent_app_country] => US
[patent_app_date] => 2015-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5078
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14950587
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/950587 | Therapeutic composition with a botulinum neurotoxin | Nov 23, 2015 | Issued |
Array
(
[id] => 10728344
[patent_doc_number] => 20160074493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'IMMUNOGENIC COMPOSITIONS CONTAINING ESCHERICHIA COLI H7 FLAGELLA AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/949291
[patent_app_country] => US
[patent_app_date] => 2015-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20091
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14949291
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/949291 | Immunogenic compositions containing | Nov 22, 2015 | Issued |
Array
(
[id] => 13125743
[patent_doc_number] => 10080786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Methods for treating pain by topical application and transdermal delivery of botulinum toxin
[patent_app_type] => utility
[patent_app_number] => 14/935886
[patent_app_country] => US
[patent_app_date] => 2015-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 26
[patent_no_of_words] => 21276
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14935886
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/935886 | Methods for treating pain by topical application and transdermal delivery of botulinum toxin | Nov 8, 2015 | Issued |
Array
(
[id] => 10692250
[patent_doc_number] => 20160038396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'DERMAL FILLER'
[patent_app_type] => utility
[patent_app_number] => 14/886817
[patent_app_country] => US
[patent_app_date] => 2015-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9838
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14886817
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/886817 | Dermal filler | Oct 18, 2015 | Issued |
Array
(
[id] => 11834711
[patent_doc_number] => 20170216431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'VACCINE PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION'
[patent_app_type] => utility
[patent_app_number] => 15/514868
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7744
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15514868
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/514868 | Vaccine pharmaceutical composition for transdermal administration | Sep 30, 2015 | Issued |
Array
(
[id] => 10822101
[patent_doc_number] => 20160168265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'Therapeutic Monoclonal Antibodies that Neutralize Botulinum Neurotoxins'
[patent_app_type] => utility
[patent_app_number] => 14/873071
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23927
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873071
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/873071 | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins | Sep 30, 2015 | Issued |
Array
(
[id] => 10662297
[patent_doc_number] => 20160008441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'METHODS FOR TREATMENT OF INCONTINENCE ASSOCIATED WITH SEXUAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/865547
[patent_app_country] => US
[patent_app_date] => 2015-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8341
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14865547
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/865547 | Methods for treatment of incontinence associated with sexual activity | Sep 24, 2015 | Issued |
Array
(
[id] => 10700551
[patent_doc_number] => 20160046698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions'
[patent_app_type] => utility
[patent_app_number] => 14/842192
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 27058
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842192
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/842192 | Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions | Aug 31, 2015 | Abandoned |
Array
(
[id] => 10805308
[patent_doc_number] => 20160151466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'BOTULINUM NEUROTOXINS WITH MODIFIED LIGHT CHAIN SPECIFITY AND METHODS FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/824986
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6999
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824986
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/824986 | Botulinum neurotoxins with modified light chain specificity and methods for producing same | Aug 11, 2015 | Issued |
Array
(
[id] => 13763531
[patent_doc_number] => 10174100
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-01-08
[patent_title] => Multivalent DNA composition for
[patent_app_type] => utility
[patent_app_number] => 14/822178
[patent_app_country] => US
[patent_app_date] => 2015-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6449
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14822178
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/822178 | Multivalent DNA composition for | Aug 9, 2015 | Issued |
Array
(
[id] => 11820626
[patent_doc_number] => 20170209563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'GLYCOCONJUGATE VACCINES COMPRISING BASIC UNITS OF A MOLECULAR CONSTRUCT EXPRESSING BUILT-IN MULTIPLE EPITOPES FOR THE FORMULATION OF A BROAD-SPECTRUM VACCINE AGAINST INFECTIONS DUE TO ENTEROPATHOGENIC BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 15/329205
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11382
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329205
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329205 | Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria | Jul 23, 2015 | Issued |
Array
(
[id] => 11743987
[patent_doc_number] => 20170198059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'CRYSTALLINE ANTIBODY FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/326341
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26562
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326341
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326341 | CRYSTALLINE ANTIBODY FORMULATIONS | Jul 12, 2015 | Abandoned |
Array
(
[id] => 10428964
[patent_doc_number] => 20150313974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'METHODS FOR TREATING HEADACHE'
[patent_app_type] => utility
[patent_app_number] => 14/797552
[patent_app_country] => US
[patent_app_date] => 2015-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 35067
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14797552
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/797552 | Methods for treating headache | Jul 12, 2015 | Issued |
Array
(
[id] => 11758532
[patent_doc_number] => 20170205401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'YEAST-BASED BIOSENSOR'
[patent_app_type] => utility
[patent_app_number] => 15/324986
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11978
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/324986 | Yeast-based biosensor | Jul 9, 2015 | Issued |
Array
(
[id] => 11757277
[patent_doc_number] => 20170204145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'ANTI-INFLAMMATORY PROPERTIES OF A SURFACE PROTEIN OF PROPIONIBACTERIUM FREUDENREICHII'
[patent_app_type] => utility
[patent_app_number] => 15/326759
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11544
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326759
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/326759 | Anti-inflammatory properties of a surface protein of propionibacterium freudenreichii | Jul 6, 2015 | Issued |
Array
(
[id] => 10678028
[patent_doc_number] => 20160024173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'NON-HEMOLYTIC LLO FUSION PROTEINS AND METHODS OF UTILIZING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/789226
[patent_app_country] => US
[patent_app_date] => 2015-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 46366
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789226
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/789226 | Non-hemolytic LLO fusion proteins and methods of utilizing same | Jun 30, 2015 | Issued |
Array
(
[id] => 11620027
[patent_doc_number] => 20170130214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'ACINETOBACTER LYSINS'
[patent_app_type] => utility
[patent_app_number] => 15/321905
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 14444
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/321905 | Acinetobacter lysins | Jun 25, 2015 | Issued |
Array
(
[id] => 10405294
[patent_doc_number] => 20150290303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/749834
[patent_app_country] => US
[patent_app_date] => 2015-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10077
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14749834
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/749834 | High frequency application of botulinum toxin therapy | Jun 24, 2015 | Issued |